SEC 13F Intelligence

Fernwood Investment Management, LLC / PLRX

Fernwood Investment Management, LLC’s Pliant Therapeutics Inc Position

Does Fernwood Investment Management, LLC own Pliant Therapeutics Inc (PLRX)? Yes425.4K shares worth $6M (+1.95% of its 13F portfolio) as of Q4 2024, down from 513.1K shares the prior filed quarter.

Position Value
$6M
Q4 2024
Shares
425.4K
% of Portfolio
+1.95%
Quarters Held
15
currently held

Position History PLRX

Reported value by quarter
Q2 ’21: $4MQ2 ’21Q3 ’21: $3MQ4 ’21: $2MQ4 ’21Q1 ’22: $2MQ2 ’22: $2MQ2 ’22Q3 ’22: $5MQ4 ’22: $6MQ4 ’22Q1 ’23: $8MQ2 ’23: $7MQ2 ’23Q3 ’23: $7MQ4 ’23: $8MQ4 ’23Q1 ’24: $7MQ2 ’24: $5MQ2 ’24Q3 ’24: $6MQ4 ’24: $6MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024425.4K$6M+1.95%
Q3 2024513.1K$6M+1.87%
Q2 2024496.3K$5M+1.65%
Q1 2024448.4K$7M+1.95%
Q4 2023423.2K$8M+2.53%
Q3 2023379.7K$7M+2.37%
Q2 2023380.7K$7M+2.45%
Q1 2023313.2K$8M+3.20%
Q4 2022304.6K$6M+2.44%
Q3 2022222.8K$5M+1.96%
Q2 2022212.2K$2M+0.73%
Q1 2022186.1K$2M+0.62%
Q4 2021174.3K$2M+0.77%
Q3 2021166.4K$3M+0.97%
Q2 2021151.1K$4M+1.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fernwood Investment Management, LLC’s full portfolio or all institutional holders of PLRX.